London-based HealthTech startup Hormona, using AI and at-home testing, secured €7.8 million in Seed funding to aid expansion and launch hormone tests.
The funding round was primarily led by Voima Ventures and co-led by SuperNode Global VC, with support from DLF Ventures and previous investors.
Hormona aims to provide real-time hormone tracking to alleviate women's hormonal issues and empower them to take control of their health.
Founded in 2020, Hormona offers personalized hormone tracking and expert guidance to manage hormonal imbalances and related conditions.
With a team of clinical experts, Hormona has raised a total of €10.2 million and is dedicated to improving women's health globally.
Inspired by the founder's personal struggles with hormonal conditions, Hormona addresses common yet often undiagnosed hormonal issues among women.
Hormona's innovative hormone tests boast over 90% accuracy compared to traditional blood sampling, making hormone tracking more accessible.
The company's app, educating women on hormonal health, has seen significant growth and engagement globally, with users from over 190 countries.
Seeking to revolutionize women's health, Hormona focuses on proactive, data-driven approaches to address hormonal imbalances effectively.
Addressing the gender health gap, Hormona provides affordable continuous hormone tracking and tailored health programs for women to enhance their well-being.